1. Home
  2. VATE vs MRNS Comparison

VATE vs MRNS Comparison

Compare VATE & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VATE
  • MRNS
  • Stock Information
  • Founded
  • VATE 1994
  • MRNS 2003
  • Country
  • VATE United States
  • MRNS United States
  • Employees
  • VATE 4024
  • MRNS N/A
  • Industry
  • VATE Metal Fabrications
  • MRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • VATE Industrials
  • MRNS Health Care
  • Exchange
  • VATE Nasdaq
  • MRNS Nasdaq
  • Market Cap
  • VATE 82.6M
  • MRNS 104.7M
  • IPO Year
  • VATE 1996
  • MRNS 2014
  • Fundamental
  • Price
  • VATE $6.10
  • MRNS $0.31
  • Analyst Decision
  • VATE
  • MRNS Buy
  • Analyst Count
  • VATE 0
  • MRNS 12
  • Target Price
  • VATE N/A
  • MRNS $4.56
  • AVG Volume (30 Days)
  • VATE 50.3K
  • MRNS 5.7M
  • Earning Date
  • VATE 11-06-2024
  • MRNS 11-05-2024
  • Dividend Yield
  • VATE N/A
  • MRNS N/A
  • EPS Growth
  • VATE N/A
  • MRNS N/A
  • EPS
  • VATE N/A
  • MRNS N/A
  • Revenue
  • VATE $1,364,600,000.00
  • MRNS $30,263,000.00
  • Revenue This Year
  • VATE N/A
  • MRNS $21.18
  • Revenue Next Year
  • VATE N/A
  • MRNS $56.42
  • P/E Ratio
  • VATE N/A
  • MRNS N/A
  • Revenue Growth
  • VATE N/A
  • MRNS 16.56
  • 52 Week Low
  • VATE $3.25
  • MRNS $0.26
  • 52 Week High
  • VATE $14.60
  • MRNS $11.26
  • Technical
  • Relative Strength Index (RSI)
  • VATE 71.67
  • MRNS 21.75
  • Support Level
  • VATE $6.18
  • MRNS $0.29
  • Resistance Level
  • VATE $6.49
  • MRNS $1.96
  • Average True Range (ATR)
  • VATE 0.43
  • MRNS 0.12
  • MACD
  • VATE 0.05
  • MRNS -0.18
  • Stochastic Oscillator
  • VATE 86.72
  • MRNS 2.41

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Share on Social Networks: